The role of regulatory T cells in cancer immunology

References

• MougiakakosDChoudhuryALladserAKiesslingRJohanssonCCRegulatory T cells in cancerAdv Cancer Res20101075711720399961
   PubMed Web of Science ®Google Scholar
• StraussLBergmannCGoodingWJohnsonJTWhitesideTLThe frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neckClin Cancer Res2007136301631117975141
   PubMed Web of Science ®Google Scholar
• WolfAMWolfDSteurerMGastlGGunsiliusEGrubeck-LoebensteinBIncrease in regulatory T cells in the peripheral blood of cancer patientsClin Cancer Res2003960661212576425
   PubMed Web of Science ®Google Scholar
• CurielTJCoukosGZouLSpecific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNat Med20041094294915322536
   PubMed Web of Science ®Google Scholar
• WolfDWolfAMRumpoldHThe expression of T cell-specific forkhead box transcription factor FOXP3 is associated with poor prognosis in ovarian carcinomaClin Cancer Res2005118326833116322292
   PubMed Web of Science ®Google Scholar
• DengLZhangHLuanYAccumulation of FOXP3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patientsClin Cancer Res2010164105411220682706
   PubMed Web of Science ®Google Scholar
• BadoualCHansSRodriguezJPrognostic value of tumor-infiltrating CD4+ T cell subpopulations in head and neck cancersClin Cancer Res200612246547216428488
   PubMed Web of Science ®Google Scholar
• TzankovAMeierCHirschmannPWentPPileriSADirnhoferSCorrelation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin’s lymphomaHaematologica20089319320018223287
   PubMed Web of Science ®Google Scholar
• CarrerasJLopez-GuillermoAFoxBCHigh numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphomaBlood20061082957296416825494
   PubMed Web of Science ®Google Scholar
• FarinhaPAl-TourahAGillKKlasaRConnorsJMGascoyneRDThe architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformationBlood201011528929519901260
   PubMed Web of Science ®Google Scholar
• DroeserRZlobecIKilicEDifferential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancersBMC Cancer20121213422471961
   PubMed Web of Science ®Google Scholar
• WhitesideTLWhat are regulatory T cells (Treg) regulating in cancer and why?Semin Cancer Biol20122232733422465232
   PubMed Web of Science ®Google Scholar
• YamaguchiTWingJBSakaguchiSTwo modes of immune suppression by FoxP39(+) regulatory T cells under inflammatory or non-inflammatory conditionsSemin Immunol20112342443022055883
   PubMed Web of Science ®Google Scholar
• WhitesideTLThe tumor microenvironment and its role in promoting tumor growthOncogene2008275904591218836471
   PubMed Web of Science ®Google Scholar
• ObergHHJurickeMKabelitzDWeschDRegulation of T cell activation by TLR ligandsEur J Cell Biol20119058259221292344
   PubMed Web of Science ®Google Scholar
• YoshieOMatsushimaKCCR4 and its ligands: from bench to bedsideInt Immunol2015271112025087232
   PubMed Web of Science ®Google Scholar
• OndondoBJonesEGodkinAGallimoreAHome sweet home: the tumor microenvironment as a haven for regulatory T cellsFront Immunol2013419723874342
   PubMed Web of Science ®Google Scholar
• LadoireSMartinFGhiringhelliFPrognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancerCancer Immunol Immunother201160790991821644034
   PubMed Web of Science ®Google Scholar
• RechAJMickRKaplanDEChangKMDomchekSMVonderheideRHHomeostasis of peripheral FOXP3(+)CD4(+) regulatory T cells in patients with early and late stage breast cancerCancer Immunol Immunother201059459960719855964
   PubMed Web of Science ®Google Scholar
• SalamaPPhillipsMGrieuFTumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancerJ Clin Oncol200927218619219064967
   PubMed Web of Science ®Google Scholar
• FreyDMDroeserRAViehlCTHigh frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patientsInt J Cancer20101262635264319856313
   PubMed Web of Science ®Google Scholar
• DuhenTDuhenRLanzavecchiaASallustoFCampbellDJFunctionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cellsBlood20121194430444022438251
   PubMed Web of Science ®Google Scholar
• FranciscoLMSalinasVHBrownKEPD-1 regulates the development, maintenance and function of induced regulatory T cellsJ Exp Med20092063015302920008522
   PubMed Web of Science ®Google Scholar
• CamisaschiCCasatiCRiniFLAG-3 expression defines a subset of CD4(+)CD25(high) Foxp3(+) regulatory T cells that are expanded at tumor sitesJ Immunol20101846545655120421648
   PubMed Web of Science ®Google Scholar
• JieHBGildener-LeapmanNLiJIntratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patientsBr J Cancer20131092629263524169351
   PubMed Web of Science ®Google Scholar
• WhitesideTLSchulerPSchillingBInduced and natural regulatory T cells in human cancerExpert Opin Biol Ther2012121383139722849383
   PubMed Web of Science ®Google Scholar
• AdeegbeDONishikawaHNatural and induced T regulatory cells in cancerFront Immunol2013419023874336
   PubMed Web of Science ®Google Scholar
• SakaguchiSSakeguchiNAsanoMItohMTodaMImmunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseasesJ Immunol1995155115111647636184
   PubMed Web of Science ®Google Scholar
• Baecher-AllanCBrownJAFreemanGJHaflerDACD4+CD25 high regulatory cells in human peripheral bloodJ Immunol20011671245125311466340
   PubMed Web of Science ®Google Scholar
• deLeeuwRJKostSEKakalJANelsonBHThe prognostic value of FOXP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literatureClin Cancer Res2012183022302922510350
   PubMed Web of Science ®Google Scholar
• DevaudCDarcyPKKershawMHFoxp3 expression in T regulatory cells and other cell lineagesCancer Immunol Immunother20146386987625063364
   PubMed Web of Science ®Google Scholar
• AllanSEPasseriniLBacchettaRThe role of 2FOXP3 isoforms in the generation of human CD4+ TregsJ Clin Invest20051153276328416211090
   PubMed Web of Science ®Google Scholar
• AbbasAKBenoistCBluestoneJARegulatory T cells: recommendations to simplify the nomenclatureNat Immunol20131430730823507634
   PubMed Web of Science ®Google Scholar
• BergmannCStraussLWangYT regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced diseaseClin Cancer Res2008143706371518559587
   PubMed Web of Science ®Google Scholar
• SchulerPJSchillingBHarasymczukMPhenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patientsEur J Immunol2012421876188522585562
   PubMed Web of Science ®Google Scholar
• deLeeuwRJKroegerDRKostSEChangPPWebbJRNelsonBHCD25 identifies a subset of CD4+FoxP3- TIL that are exhausted yet prognostically favorable in human ovarian cancerCancer Immunol Res2014319
   Web of Science ®Google Scholar
• WhitesideTLInduced regulatory T cells in inhibitory microenvironments created by cancerExpert Opin Biol Ther201414101411142524934899
   PubMed Web of Science ®Google Scholar
• StraussLBergmannCSzczepanskiMJLangSKirkwoodJMWhitesideTLExpression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppressionJ Immunol200818052967298018292519
   PubMed Web of Science ®Google Scholar
• MandapathilMSzczepanskiMHarasymczukMCD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinomaOncoimmunology20121565966922934258
   PubMed Web of Science ®Google Scholar
• LiuWPutnamALXu-YuZCD127 expression inversely correlates with FOXP3 and suppressive function of human CD4+ Treg cellsJ Exp Med20062031701171116818678
   PubMed Web of Science ®Google Scholar
• SantegoetsSDijkgraafEBattagliaAMonitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometryIn press2015
   Google Scholar
• SalomonBLenschowDJRheeLB7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetesImmunity20001243144010795741
   PubMed Web of Science ®Google Scholar
• MandapathilMHilldorferBSzczepanskiMJGeneration and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cellsJ Biol Chem20102857176718619858205
   PubMed Web of Science ®Google Scholar
• MandapathilMSzczepanskiMJSzajnikMAdenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cellsJ Biol Chem2010285275712758020558731
   PubMed Web of Science ®Google Scholar
• BergmannCStraussLZeidlerRLangSWhitesideTLExpansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinomaCancer Res2007678865887317875728
   PubMed Web of Science ®Google Scholar
• StraussLBergmannCWhitesideTLHuman circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosisJ Immunol20091821469148019155494
   PubMed Web of Science ®Google Scholar
• GaoXZhuYLiGTIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progressionPLoS One20127e3067622363469
   PubMed Web of Science ®Google Scholar
• YanJZhangYZhangJPLiangJLiLZhengLTim-3 expression defines regulatory T cells in human tumorsPLoS One20138e5800623526963
   PubMed Web of Science ®Google Scholar
• PabbisettySKRabacalWMasedaDKLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell productionProc Natl Acad Sci U S A2014111269579958424979767
   PubMed Web of Science ®Google Scholar
• SzczepanskiMJSzajnikMCzystowskaMIncreased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemiaClin Cancer Res2009153325333219417016
   PubMed Web of Science ®Google Scholar
• SchmittEGWilliamsCBGeneration and function of induced regulatory T cellsFront Immunol2013415223801990
   PubMed Web of Science ®Google Scholar
• RuitenbergJJBoyceCHingoraniRPutnamAGhanekarSARapid assessment of in vitro expanded human regulatory T cells functionJ Immunol Methods20113729510621781972
   PubMed Web of Science ®Google Scholar
• CanavanJBAfzaliBScottàCA rapid diagnostic test for human regulatory T cell function to enable regulatory T cell therapyBlood2012119e57e6622219224
   PubMed Web of Science ®Google Scholar
• WhitesideTLRegulatory T cell (Treg) assays: repertoire, functions and clinical importance of human TregDetrichBHamiltonRGFoldsJDManual of Molecular and Clinical Laboratory Immunology8th edWashingtonASM PressIn press2015
   Google Scholar
• WhitesideTLJacksonEKAdenosine and prostaglandin e2 production by human inducible regulatory T cells in health and diseaseFront Immunol2013421223898333
   PubMed Web of Science ®Google Scholar
• PolanskyJKSchreiberLThelemannCMethylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cellsJ Mol Med (Berl)2010881029104020574810
   PubMed Web of Science ®Google Scholar
• KalathilSLugadeAAMillerAIyerRThanavalaYHigher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T cell functionalityCancer Res2013732435244423423978
   PubMed Web of Science ®Google Scholar
• JacobsJFIdemaAJBolKFRegulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumorsNeuro Oncol20091139440219028999
   PubMed Web of Science ®Google Scholar
• ButtAQMillsKHImmunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccinesOncogene2014334623463124141774
   PubMed Web of Science ®Google Scholar
• NirschiCJDrakeCGMolecular pathways: coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunoatherapyClin Cancer Res2013194917492423868869
   PubMed Web of Science ®Google Scholar
• WooSRTurnisMEGoldbergMVImmune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escapeCancer Res20127291792722186141
   PubMed Web of Science ®Google Scholar
• PandiyanPZhengLIshiharaSReedJLenardoMJCD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cellsNat Immunol200781353136217982458
   PubMed Web of Science ®Google Scholar
• CzystowskaMStraussLBergmannCSzajnikMRabinowichHWhitesideTLReciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2)J Mol Med (Berl)20108857758820225066
   PubMed Web of Science ®Google Scholar
• Hyun-BaeJSchulerPJLeeSCCTLA-4+ regulatory T cells are increased in cetuximab treated head and neck cancer patients, suppress NK cell cytotoxicity and correlate with poor prognosisCancer Res2015
   Web of Science ®Google Scholar
• Muller-HaegeleSMullerLWhitesideTLImmunoregulatory activity of adenosine and its role in human cancer progressionExpert Rev Clin Immunol201410789791424871693
   PubMed Web of Science ®Google Scholar
• KumaiTOikawaKAokiNTumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitorJ Transl Med20141226525240937
   PubMed Web of Science ®Google Scholar
• AntonioliLBlandizziCPacherPHaskoGImmunity, inflammation and cancer: a leading role for adenosineNat Rev Cancer20131384285724226193
   PubMed Web of Science ®Google Scholar
• HaskoGLindenJCronsteinBPacherPAdenosine receptors: therapeutic aspects for inflammatory and immune diseasesNat Rev Drug Discov2008775977018758473
   PubMed Web of Science ®Google Scholar
• BorsellinoGKleinewietfeldMDi MitriDExpression of ectonucleotidase CD39 by FoxP3+ Treg cells: hydrolysis of extracellular ATP and immune suppressionBlood20071101225123217449799
   PubMed Web of Science ®Google Scholar
• DeaglioSDwyerKMGaoWAdenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionJ Exp Med20072041257126517502665
   PubMed Web of Science ®Google Scholar
• SchulerPJSazeZHongCSHuman CD4(+) CD39(+) regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73(+) exosomes or CD73(+) cellsClin Exp Immunol2014177253154324749746
   PubMed Web of Science ®Google Scholar
• MandapathilMWhitesideTLTargeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E2 cooperationExpert Opin Biol Ther2011111203121421702720
   PubMed Web of Science ®Google Scholar
• SzajnikMCzystowskaMSzczepanskiMJMandapathilMWhitesideTLTumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg)PLoS One20105e1146920661468
   PubMed Web of Science ®Google Scholar
• MarigoIDolcettiLSerafiniPZanovelloPBronteVTumor-induced tolerance and immune suppression by myeloid derived suppressor cellsImmunol Rev200822216217918364001
   PubMed Web of Science ®Google Scholar
• ZhouAXKozhayaLFujiiHUnutmazDGarp-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivoJ Immunol20131905057506423576681
   PubMed Web of Science ®Google Scholar
• WhiteRAMalkoskiSPWangXJTGFβ signaling in head and neck squamous cell carcinomaOncogene2010295437544620676130
   PubMed Web of Science ®Google Scholar
• DelgoffeGMWooSRTurnisMEStability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axisNature201350125225623913274
   PubMed Web of Science ®Google Scholar
• ChaudharyBKhaledYSAmmoriBJElkordENeuropilin 1: function and therapeutic potential in cancerCancer Immunol Immunother201463819924263240
   PubMed Web of Science ®Google Scholar
• GalonJPagèsFMarincolaFMThe immune score as a new possible approach for the classification of cancerJ Transl Med201210122214470
   PubMed Web of Science ®Google Scholar
• FridmanWHGalonJPagèsFTartourESautès-FridmanCKroemerGPrognostic and predictive impact of intra- and peritumoral immune infiltratesCancer Res201171175601560521846822
   PubMed Web of Science ®Google Scholar
• NoshoKBabaYTanakaNTumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature reviewJ Pathol201022235036620927778
   PubMed Web of Science ®Google Scholar
• LongSABucknerJHCD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers gameJ Immunol20111872061206621856944
   PubMed Web of Science ®Google Scholar
• KavanaghBO’BrienSLeeDCTLA4 blockade expands FOXP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashionBlood200811241175118318523152
   PubMed Web of Science ®Google Scholar
• SimGCMartin-OrozcoNJinLIL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patientsJ Clin Invest201412419911024292706
   PubMed Web of Science ®Google Scholar
• SchulerPJHarasymczukMSchillingBEffects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancerClin Cancer Res201319236585659624097865
   PubMed Web of Science ®Google Scholar
• ColomboMPPiconeseSRegulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapyNat Rev Cancer2007788088717957190
   PubMed Web of Science ®Google Scholar
• MoltedoBHemmersSRudenskyAYRegulatory T cell ablation causes acute T cell lymphopeniaPLoS One20149e8676224466225
   PubMed Web of Science ®Google Scholar
• LeDTJaffeeEMRegulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspectiveCancer Res201272143439344422761338
   PubMed Web of Science ®Google Scholar
• RechAJVonderheideRHClinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cellsAnn N Y Acad Sci200911749910619769742
   PubMed Web of Science ®Google Scholar
• BaurASLutzMBSchiererSDenileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting TregBlood2013122132185219423958949
   PubMed Web of Science ®Google Scholar
• FinkeJHRiniBIrelandJSunitinib reverses type-1 immune suppression and decreases T regulatory cells in renal carcinoma patientsClin Cancer Res200814206674668218927310
   PubMed Web of Science ®Google Scholar
• ElkordEAlcantar-OrozcoEMDovediSJT regulatory cells in cancer: recent advances and therapeutic potentialExp Opin Biol Ther20101015731586
   PubMed Web of Science ®Google Scholar
• NishikawaHSakaguchiSRegulatory T cells in cancer immunotherapyCurr Opin Immunol2014271724413387
   PubMed Web of Science ®Google Scholar
• WhitesideTLDisarming suppressor cells to improve immunotherapyCancer Immunol Immunother20126128328822146892
   PubMed Web of Science ®Google Scholar
• RechAJMickRMartinSCD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsSci Transl Med20124134134ra62
   PubMed Web of Science ®Google Scholar
• ChengGYuAMalekTRT cell tolerance and the multi-functional role of IL-2R signaling in T regulatory cellsImmunol Rev2011241637621488890
   PubMed Web of Science ®Google Scholar
• WhitesideTLInhibiting the inhibitors: evaluating agents targeting cancer immunosuppressionExpert Opin Biol Ther2010101019103520415597
   PubMed Web of Science ®Google Scholar
• StaggJSmythMJExtracellular adenosine triphosphate and adenosine in cancerOncogene2010305346535820661219
   PubMed Web of Science ®Google Scholar
• OhtaAKiniROhtaASubramanianMMadasuMSitkovskyMThe development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathwayFront Immunol2012319022783261
   PubMed Web of Science ®Google Scholar
• StaggJDivisekeraUMcLaughlinNAnti-CD73 antibody therapy inhibits breast tumor growth and metastasisProc Natl Acad Sci U S A20101071547155220080644
   PubMed Web of Science ®Google Scholar
• BastidJCottalorda-RegairazAAlbericiGBonnefoyNEliaouJFBensussanAENTPD1/CD39 is a promising therapeutic target in oncologyOncogene201332141743175122751118
   PubMed Web of Science ®Google Scholar
• HodiFSO’DaySJMcDermottDFImproved survival with ipilimumab in patients with metastatic melanomaN Engl J Med201036371172320525992
   PubMed Web of Science ®Google Scholar
• BrahmerJRTykodiSSChowLQSafety and activity of anti-PD-L1 antibody in patients with advanced cancerN Engl J Med20123662455246522658128
   PubMed Web of Science ®Google Scholar
• CurranMAMontalvoWYahitaHAllisonJPPD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells with B16 melanoma tumorsProc Natl Acad Sci U S A20101074275428020160101
   PubMed Web of Science ®Google Scholar
• WhitesideTLRegulatory T cell subsets in human cancer: are they regulating for or against tumor progression?Cancer Immunol Immunother201463677224213679
   PubMed Web of Science ®Google Scholar
• WhitesideTLImmune modulation of T-cell and NK-cell (natural killer) cell activities by TEX (tumor derived exosomes)Biochem Soc Trans20134124525123356291
   PubMed Web of Science ®Google Scholar
• ElkordEAl-RamadiBKHelios expression in FoxP3(+) T regulatory cellsExpert Opin Biol Ther2012121423142522827571
   PubMed Web of Science ®Google Scholar
• FerraroAD’AliseAMRajTInterindividual variation in human T regulatory cellsProc Natl Acad Sci U S A2014111E1111E112024610777
   PubMed Web of Science ®Google Scholar
• LitzingerMTFernandoRCurielTJGrosenbachDWSchlomJPalenaCIL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunityBlood20071103192320117616639
   PubMed Web of Science ®Google Scholar
• PerainoJSZhangHRajasekeraPVDiphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cellsJ Immunol Methods2014405576624462799
   PubMed Web of Science ®Google Scholar
• SmithALRobinTPFordHLMolecular pathways: targeting the TGF-β pathway for cancer therapyClin Cancer Res2012184514452122711703
   PubMed Web of Science ®Google Scholar
• WeberJImmune checkpoint proteins: a new therapeutic paradigm for cancer – preclinical background: CTLA-4 and PD-1 blockadeSemin Oncol20103743043921074057
   PubMed Web of Science ®Google Scholar
• PardollDMThe blockade of immune checkpoints in cancer immunotherapyNat Rev Cancer20121225226422437870
   PubMed Web of Science ®Google Scholar
• CallahanMKWolchokJDAt the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapyJ Leukoc Biol201394415323667165
   PubMed Web of Science ®Google Scholar
• ChenXBäumelMMännelDNHowardOMOppenheimJJInteraction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cellsJ Immunol200717915416117579033
   PubMed Web of Science ®Google Scholar
• NagarMJacob-HirschJVernitskyHTNF activates a NF-kappaB-regulated cellular program in human CD45RA-regulatory T cells that modulates their suppressive functionJ Immunol20101843570358120181891
   PubMed Web of Science ®Google Scholar
• CohenADDiabAPeralesMAAgonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityCancer Res2006664904491216651447
   PubMed Web of Science ®Google Scholar
• LutsiakMESemnaniRTDe PascalisRKashmiriSVSchlomJSabzevariHInhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamideBlood20051052862286815591121
   PubMed Web of Science ®Google Scholar
• van der MostRGCurrieAJMahendranSTumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapyCancer Immunol Immunother2009581219122819052741
   PubMed Web of Science ®Google Scholar
• ZhaoJCaoYLeiZYangZZhangBHuangBSelective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levelsCancer Res2010704850485820501849
   PubMed Web of Science ®Google Scholar
• BeyerMKochanekMDarabiKReduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabineBlood20051062018202515914560
   PubMed Web of Science ®Google Scholar
• AliKSoondDRPiñeiroRInactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancerNature201451040741124919154
   PubMed Web of Science ®Google Scholar
• BachanovaVCooleySDeforTEClearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion proteinBlood20141233855386324719405
   PubMed Web of Science ®Google Scholar
• HuijtsCMSantegoetsSJvan den EertweghAJPhase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancerBMC Cancer20111150522129044
   PubMed Web of Science ®Google Scholar